|
SOX6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.011100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.562600E-04 |
| Normal-vs-Stage2 |
1.817250E-01 |
| Normal-vs-Stage3 |
2.554500E-04 |
| Normal-vs-Stage4 |
1.7765199999964E-05 |
| Stage1-vs-Stage2 |
1.202810E-01 |
| Stage1-vs-Stage3 |
3.978000E-01 |
| Stage1-vs-Stage4 |
8.385700E-02 |
| Stage2-vs-Stage3 |
5.742400E-02 |
| Stage2-vs-Stage4 |
1.747640E-02 |
| Stage3-vs-Stage4 |
4.496400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.3018999999942E-05 |
| Normal-vs-AfricanAmerican |
1.336320E-02 |
| Normal-vs-Asian |
1.163090E-03 |
| Caucasian-vs-AfricanAmerican |
9.417000E-01 |
| Caucasian-vs-Asian |
9.030200E-01 |
| AfricanAmerican-vs-Asian |
9.979000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.95359999972156E-07 |
| Normal-vs-Female |
1.896730E-03 |
| Male-vs-Female |
1.133890E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.369600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.057140E-03 |
| Normal-vs-Age(61-80Yrs) |
9.702200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.057000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.287200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.473600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.644580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.756400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.321400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.500030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.691890E-02 |
| Classical-VS-Follicular |
7.028200E-02 |
| Classical-VS-Other |
7.764000E-02 |
| Classical-VS-Normal |
3.366100E-04 |
| Tall-VS-Follicular |
1.643050E-03 |
| Tall-VS-Other |
4.124000E-01 |
| Tall-VS-Normal |
1.99320000004999E-06 |
| Follicular-VS-Other |
4.484300E-02 |
| Follicular-VS-Normal |
9.937600E-02 |
| Other-VS-Normal |
2.016400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.863100E-03 |
| Normal-vs-N1 |
3.32560000004811E-06 |
| N0-vs-N1 |
2.858200E-02 |
|
|
